Author

Rebecca Rogers

Institute of Cancer Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Aimee L. DavidsoniD· 1 shared Alan G. MackayiD· 1 shared Andrea Garrett· 1 shared Ann‐Marie PatchiD· 1 shared Anna Burford· 1 shared Asmerom Tesfamariam SengaliD· 1 shared Chris JonesiD· 1 shared Claire Dobinson· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aimee L. DavidsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Combination of ALK2 and cholesterol targeting agents exploits linked genetic and metabolic dependencies in diffuse midline glioma

Rebecca Rogers, Alan G. Mackay, Yura Grabovska, Diana Carvalho, Claire Dobinson, Anna Burford, Valeria Molinari, Rita Pereira, Laura Bevington, Ruth Ruddle, Josephine Nkrumah, Haider Tari, Jiin Song, Drenusha Sejdiu, Nicole Chew, , Chris Jones

This study identifies a combinatorial strategy using ALK2 inhibitors and statins to target metabolic dependencies in diffuse midline glioma.

bioRxiv · Sep 23, 2026 · PreprintCancer Biology

Genomic analysis of patient-derived xenograft models reveals intra-tumor heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib

Vanessa Bonazzi, Olga Kondrashova, Deborah S. Smith, Kátia Nones, Asmerom Tesfamariam Sengal, Robert J. Ju, Leisl Packer, Lambros T. Koufariotis, Stephen H. Kazakoff, Aimee L. Davidson, Priya Ramarao-Milne, Vanessa Lakis, Felicity Newell, Rebecca Rogers, Claire M. Davies, , Pamela M. Pollock

The paper develops endometrial cancer PDX models that capture tumor heterogeneity and predict response to talazoparib.

Genome Medicine · Jan 10, 2022Peer-reviewedGenomics